ArticleBMC cancer2015

Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.

Martina Broecker-Preuss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.